Prevention of hemolysis effects on insulin assay;PREVENTION DES EFFECTS DE L'HEMOLYSE SUR LE DOSAGE D'INSULINE

Immuno-Analyse et Biologie Specialisee

Volumn 12, Issue 4, 1997, Pages 206-208

  Sapin, R ^a   Gasser, F ^a   Grucker, D ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Inhibitor; Interference; N ethylmaleimide; Preanalytical stage

Indexed keywords

INSULIN; INSULINASE; N ETHYLMALEIMIDE;

ARTICLE; BLOOD CELL; CONTROLLED STUDY; DRUG DETERMINATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN DEGRADATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TEMPERATURE;

EID: 0030817518     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(97)89658-5     Document Type: Article

References (16)

1. 1 Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder M. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993 ; 39 : 578-82
2. 2 Authier F, Posner BI, Bergeron JJM. Insulin-degrading enzyme [Review]. Clin Invest Med 1996 ; 19 : 149-60
3. 3 Caillot-Augusseau A, Petit M, Pernod J, Clavier A., Vergely N, Soler C, Benabdesselam F. Specimen hemolysis and insulin measurement assay [Abstract]. ELAS 3rd Scientific Meeting, Lyon, 27-29 mars 1996 :143
4. 4 Chevenne D, Letailleur A, Trivin F, Porquet D. Dosages des proinsulines, insuline et peptide-C plasmatiques. Ann Biol Clin 1995 ; 53 : 3-9
5. 5 Crowthers NJ, Gray IP. Immunometric assays of insulin and its precursors. J Clin Ligand Assay 1996 ; 19 : 112-20
6. 6 D'Costa M, Feld R, Laxdal V, Trundle D, Collinsworth WL. A multicenter evaluation of the Boehringer Mannheim ES 300 immunoassay system. Clin Biochem 1993 ; 26 : 51-7
7. 7 Duckworth WC, Hamel FG, Bennett R, Ryan MP, Roth RA. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin. J Biol Chem 1990 ; 265 : 2984-7
8. 8 Livesey JH, Hodgkinson SC, Roud HR, Donald RA. Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin, and insulin in plasma. Clin Biochem 1980 ; 13 : 151-5
9. 9 O'Rahilly S, Burnett MA, Smith RF, Darley JH, Turner RC. Haemolysis affects insulin but not C-peptide immunoassay. Diabetologia 1987 ; 30 : 394-6
10. 10 Sapin R. Recent insulin immunoassays: improvements and limits. J Clin Ligand Assay 1996 ; 19 (suppl 1) : 100S-10S
11. 11 Sapin R. Anti-insulin antibodies in insulin immunometric assays: a still possible pitfall. Eur J Clin Chem Clin Biochem 1997 ; 35 : 365-7
12. e Colloque CORATA, Besançon, 17 octobre 1990
13. 13 Sapin R, Blicklé JF, Gasser F. Dosages d'insuline: comparaison IMx Abbott, RIA Pasteur lors d'épreuves d'hyperglycémie par voie orale. Immunoanal Biol Spéc 1994 ; 9 : 94-8
14. e Colloque CORATA, Strasbourg 1996, 240
15. 15 Saric T, Seitz HJ, Pavelic K. Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme. Mol Cell Endocrinol 1994 ; 106 : 23-9
16. 16 Shi K, Yokono K, Baba S, Roth RA. Purification and characterization of insulin-degrading enzyme from human erythrocytes. Diabetes 1986 ; 35 : 675-83